Header Logo

Connection

Kate Lapane to Cardiovascular Diseases

This is a "connection" page, showing publications Kate Lapane has written about Cardiovascular Diseases.
Connection Strength

0.676
  1. CastaƱeda-Avila MA, Lapane KL, Jesdale BM, Crawford SL, Epstein MM. Variation in Colorectal Cancer Screening Practices According to Cardiovascular Disease Status and Race/Ethnicity. J Racial Ethn Health Disparities. 2021 02; 8(1):166-173.
    View in: PubMed
    Score: 0.133
  2. Lapane KL, Barbour MM, Van Haaren A, Gambassi G. Antiischemic therapy in patients with coronary heart disease living in long-term care. Systematic Assessment of Geriatric Drug Use by Epidemiology (SAGE) Group. Pharmacotherapy. 1999 May; 19(5):627-34.
    View in: PubMed
    Score: 0.124
  3. Campitelli MA, Maxwell CJ, Maclagan LC, Ko DT, Bell CM, Jeffs L, Morris AM, Lapane KL, Daneman N, Bronskill SE. One-year survival and admission to hospital for cardiovascular events among older residents of long-term care facilities who were prescribed intensive- and moderate-dose statins. CMAJ. 2019 01 14; 191(2):E32-E39.
    View in: PubMed
    Score: 0.121
  4. Assaf AR, Parker D, Lapane KL, Coccio E, Evangelou E, Carleton RA. Does the Y chromosome make a difference? Gender differences in attempts to change cardiovascular disease risk factors. J Womens Health (Larchmt). 2003 May; 12(4):321-30.
    View in: PubMed
    Score: 0.041
  5. Eaton CB, Lapane KL, Murphy JB, Hume AL. Effect of statin (HMG-Co-A-Reductase Inhibitor) use on 1-year mortality and hospitalization rates in older patients with cardiovascular disease living in nursing homes. J Am Geriatr Soc. 2002 Aug; 50(8):1389-95.
    View in: PubMed
    Score: 0.039
  6. Eaton CB, Lapane KL, Garber CE, Gans KM, Lasater TM, Carleton RA. Effects of a community-based intervention on physical activity: the Pawtucket Heart Health Program. Am J Public Health. 1999 Nov; 89(11):1741-4.
    View in: PubMed
    Score: 0.032
  7. Wang JS, Carson EC, Lapane KL, Eaton CB, Gans KM, Lasater TM. The effect of physician office visits on CHD risk factor modification as part of a worksite cholesterol screening program. Prev Med. 1999 Mar; 28(3):221-8.
    View in: PubMed
    Score: 0.031
  8. Parker DR, Lapane KL, Lasater TM, Carleton RA. Short stature and cardiovascular disease among men and women from two southeastern New England communities. Int J Epidemiol. 1998 Dec; 27(6):970-5.
    View in: PubMed
    Score: 0.030
  9. Bostom AG, Shemin D, Lapane KL, Nadeau MR, Sutherland P, Chan J, Rozen R, Yoburn D, Jacques PF, Selhub J, Rosenberg IH. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients. Atherosclerosis. 1996 Jun; 123(1-2):193-202.
    View in: PubMed
    Score: 0.025
  10. Bostom AG, Shemin D, Lapane KL, Hume AL, Yoburn D, Nadeau MR, Bendich A, Selhub J, Rosenberg IH. High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int. 1996 Jan; 49(1):147-52.
    View in: PubMed
    Score: 0.025
  11. Flint PM, Lapane KL, Barbour MM, Derby CA, Carleton RA, Hume AL. Cardiovascular risk profiles of oral contraceptive users and nonusers: a population-based study. Prev Med. 1995 Nov; 24(6):586-90.
    View in: PubMed
    Score: 0.024
  12. Bostom AG, Shemin D, Lapane KL, Miller JW, Sutherland P, Nadeau M, Seyoum E, Hartman W, Prior R, Wilson PW, et al. Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study. Atherosclerosis. 1995 Apr 07; 114(1):93-103.
    View in: PubMed
    Score: 0.023
  13. Liperoti R, Onder G, Landi F, Lapane KL, Mor V, Bernabei R, Gambassi G. All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study. J Clin Psychiatry. 2009 Oct; 70(10):1340-7.
    View in: PubMed
    Score: 0.016
  14. Spooner JJ, Lapane KL, Hume AL, Mor V, Gambassi G. Pharmacologic treatment of diabetes in long-term care. J Clin Epidemiol. 2001 May; 54(5):525-30.
    View in: PubMed
    Score: 0.009
  15. Hume AL, Barbour MM, Lapane KL, Assaf AR, Carleton RA. Prevalence and descriptors of aspirin use as an antiplatelet agent in two New England communities. Ann Pharmacother. 1993 Apr; 27(4):442-4.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.